BETA
Developer of a pulmonary-embolism thrombolysis catheter combining infusion, angiography and treatment monitoring.
Flow Medical is the Chicago pulmonary-embolism company operating as Flow Medical Solutions, Inc. Its physician founders are Jonathan Paul, an interventional cardiologist, and Osman Ahmed, an interventional radiologist, both associated with the University of Chicago.
The company is developing an all-in-one angiography, infusion and monitoring catheter for catheter-directed thrombolysis. An integrated feedback mechanism is intended to help physicians follow clot resolution and tailor lytic therapy. These are development aims, rather than established evidence that the device reduces complications.
Jennifer Fried is Co-Founder and CEO. The company announced a $5 million seed round in December 2024, including $2 million previously secured from friends and family. This profile concerns the pulmonary-embolism developer at flowmedical.co; marketing authorization and routine commercial availability have not been established in the reviewed sources.
Flow’s pulmonary-embolism catheter program remains in development in the reviewed disclosures. No product-matched FDA marketing decision was established. LungFlow devices from Free Flow Medical and a Total Flow Medical cannula belong to different companies and are excluded. [1][3][5]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [7][8]
Latest recorded source review: 2026-10-20.
No routinely marketed devices established in the reviewed scope.
Catheter development and clinical/regulatory preparation; no FDA marketing decision established. [1][3]
Integrated angiography, infusion and monitoring catheter under development. [1]
Investigational / in developmentDevelopment program; no routine commercial availability established.
Round included $2 million previously secured; not $7 million of additive funding. [3]
Accessed 10/29/2026